Seres Therapeutics, Inc.

MCRB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$30,793$127,965$163,030$180,002
Short-Term Investments$0$0$18,311$110,704
Receivables$4,751$0$0$0
Inventory$0$29,647$0$0
Other Curr. Assets$3,130$17,798$13,423$12,922
Total Curr. Assets$38,674$175,410$194,764$303,628
Property Plant & Equip (Net)$92,437$108,031$133,969$36,146
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$9,586$495
Tax Assets$0$0$0$0
Other NC Assets$8,699$75,159$10,465$14,590
Total NC Assets$101,136$183,190$154,020$51,231
Other Assets$0$0$0$0
Total Assets$139,810$358,600$348,784$354,859
Liabilities
Payables$4,079$3,641$17,440$13,735
Short-Term Debt$8,674$5,587$4,057$6,610
Tax Payable$0$0$0$0
Deferred Revenue$0$7,730$4,259$16,819
Other Curr. Liab.$28,469$81,701$59,840$45,094
Total Curr. Liab.$41,222$98,659$85,596$82,258
LT Debt$82,966$193,196$158,533$42,601
Deferred Rev, NC$0$95,364$92,430$86,998
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,838$16,237$1,442$11,495
Total NC Liab.$84,804$304,797$252,405$141,094
Other Liabilities$0$0$0$0
Cap. Leases$91,640$97,239$111,543$24,568
Total Liabilities$126,026$403,456$338,001$223,352
Equity
Pref Stock$0$0$0$0
Common Stock$173$135$125$92
Retained Earnings-$978,099-$978,235-$864,511-$614,354
AOCI$0$0-$12-$60
Other Equity$991,710$933,244$875,181$745,829
Total Equity$13,784-$44,856$10,783$131,507
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$139,810$358,600$348,784$354,859
Net Debt$60,847$70,818-$440-$130,791
Seres Therapeutics, Inc. (MCRB) Financial Statements & Key Stats | AlphaPilot